Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells

de Gruijl, 2008, Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines, Cancer Immunol Immunother, 57, 1569, 10.1007/s00262-008-0536-z

Chiang, 2010, Whole tumor antigen vaccines, Semin Immunol, 22, 132, 10.1016/j.smim.2010.02.004

Guo, 2013, Therapeutic cancer vaccines: past, present and future, Adv Cancer Res, 119, 421, 10.1016/B978-0-12-407190-2.00007-1

Dubensky, 2010, Adjuvants for cancer vaccines, Semin Immunol, 22, 155, 10.1016/j.smim.2010.04.007

Chiang, 2011, Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines, Int Rev Immunol, 30, 150, 10.3109/08830185.2011.572210

Li, 2017, TLR agonists as adjuvants for cancer vaccines, Adv Exp Med Biol, 1024, 195, 10.1007/978-981-10-5987-2_9

Copier, 2006, Overview of tumor cell-based vaccines, Int Rev Immunol, 25, 297, 10.1080/08830180600992472

Dhodapkar, 2008, Interactions of tumor cells with dendritic cells: balancing immunity and tolerance, Cell Death Differ, 15, 39, 10.1038/sj.cdd.4402247

Herber, 2010, Lipid accumulation and dendritic cell dysfunction in cancer, Nat Med, 16, 880, 10.1038/nm.2172

D'Souza-Schorey, 2012, Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers, Genes Dev, 26, 1287, 10.1101/gad.192351.112

Lee, 2011, Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris', Semin Immunopathol, 33, 455, 10.1007/s00281-011-0250-3

Quesenberry, 2010, Cellular phenotype switching and microvesicles, Adv Drug Deliv Rev, 62, 1141, 10.1016/j.addr.2010.06.001

Mause, 2010, Microparticles: protagonists of a novelcommunication network for intercellular information exchange, Circ Res, 107, 1047, 10.1161/CIRCRESAHA.110.226456

Tetta, 2013, Extracellular vesicles as an emerging mechanism of cell-to-cell communication, Endocrine, 44, 11, 10.1007/s12020-012-9839-0

Tang, 2012, Delivery of chemotherapeutic drugs in tumour cell-derived microparticles, Nat Commun, 3, 1282, 10.1038/ncomms2282

Cao, 2017, Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages, Cell Mol Immunol, 14, 395, 10.1038/cmi.2015.30

Zhang, 2015, Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling, Cancer Immunol Res, 3, 196, 10.1158/2326-6066.CIR-14-0177

Qiu, 2015, Cytomegalovirus-based vaccine expressing a modified tumor antigen induces potent tumor-specific CD8(+) T-cell response and protects mice from melanoma, Cancer Immunol Res, 3, 536, 10.1158/2326-6066.CIR-14-0044

Naik, 2005, Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures, J Immunol, 174, 6592, 10.4049/jimmunol.174.11.6592

Xiao, 2016, The non-canonical Wnt pathway negatively regulates dendritic cell differentiation by inhibiting the expansion of Flt3(+) lymphocyte-primed multipotent precursors, Cell Mol Immunol, 13, 593, 10.1038/cmi.2015.39

Segura, 2009, Antigen presentation by dendritic cells in vivo, Curr Opin Immunol, 21, 105, 10.1016/j.coi.2009.03.011

Ding, 2016, The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation, Nat Immunol, 17, 1167, 10.1038/ni.3535

Saftig, 2009, Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function, Nat Rev Mol Cell Biol, 10, 623, 10.1038/nrm2745

Settembre, 2011, TFEB links autophagy to lysosomal biogenesis, Science, 332, 1429, 10.1126/science.1204592

Sun-Wada, 2009, Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification, J Cell Sci, 122, 2504, 10.1242/jcs.050443

Mantegazza, 2008, NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells, Blood, 112, 4712, 10.1182/blood-2008-01-134791

Savina, 2006, NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells, Cell, 126, 205, 10.1016/j.cell.2006.05.035

Shepherd, 1993, TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective, Cell, 74, 577, 10.1016/0092-8674(93)80058-M

Pu, 2015, BORC, a multisubunit complex that regulates lysosome positioning, Dev Cell, 33, 176, 10.1016/j.devcel.2015.02.011

Rosa-Ferreira, 2011, Arl8 and SKIP act together to link lysosomes to kinesin-1, Dev Cell, 21, 1171, 10.1016/j.devcel.2011.10.007

Marshansky, 2008, The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function, Curr Opin Cell Biol, 20, 415, 10.1016/j.ceb.2008.03.015

Jin, 2017, Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway, Biomaterials, 113, 93, 10.1016/j.biomaterials.2016.10.036

Kaisho, 2001, Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice, Trends Immunol, 22, 78, 10.1016/S1471-4906(00)01811-1

Shumilina, 2011, Ca2+ signaling in the regulation of dendritic cell functions, Am J Physiol Cell Physiol, 300, C1205, 10.1152/ajpcell.00039.2011

Haller, 1996, The lysosomal compartment as intracellular calcium store in MDCK cells: a possible involvement in InsP3-mediated Ca2+ release, Cell Calcium, 19, 157, 10.1016/S0143-4160(96)90084-6

Samie, 2009, The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1, Pflugers Arch, 459, 79, 10.1007/s00424-009-0716-5

Lee, 2012, Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling, Biochem Pharmacol, 84, 425, 10.1016/j.bcp.2012.05.009

Pastore, 2016, TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages, Autophagy, 12, 1240, 10.1080/15548627.2016.1179405

Medina, 2015, Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB, Nat Cell Biol, 17, 288, 10.1038/ncb3114

Finn, 2003, Cancer vaccines: between the idea and the reality, Nat Rev Immunol, 3, 630, 10.1038/nri1150

Yang, 2011, The roles of tumor-derived exosomes in cancer pathogenesis, Clin Dev Immunol, 2011, 842849, 10.1155/2011/842849

Zhang, 2015, Tumor cell-derived microparticles: a new form of cancer vaccine, Oncoimmunology, 4, e1017704, 10.1080/2162402X.2015.1017704

Dong, 2017, Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity, Oncoimmunology, 6, e1282589, 10.1080/2162402X.2017.1282589

Ma, 2016, Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression, Oncoimmunology, 5, e1118599, 10.1080/2162402X.2015.1118599

Mellman, 2001, Dendritic cells: specialized and regulated antigen processing machines, Cell, 106, 255, 10.1016/S0092-8674(01)00449-4

Blander, 2006, On regulation of phagosome maturation and antigen presentation, Nat Immunol, 7, 1029, 10.1038/ni1006-1029

Sokolovska, 2013, Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function, Nat Immunol, 14, 543, 10.1038/ni.2595

Rybicka, 2012, Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner, EMBO J, 31, 932, 10.1038/emboj.2011.440

Dumitriu, 2007, The secretion of HMGB1 is required for the migration of maturing dendritic cells, J Leukoc Biol, 81, 84, 10.1189/jlb.0306171

Berridge, 2002, The endoplasmic reticulum: a multifunctional signaling organelle, Cell Calcium, 32, 235, 10.1016/S0143416002001823

Zong, 2009, The two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release from lysosomal stores, Pflugers Arch, 458, 891, 10.1007/s00424-009-0690-y

Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci Signal, 5, ra42, 10.1126/scisignal.2002790

Visvikis, 2014, Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes, Immunity, 40, 896, 10.1016/j.immuni.2014.05.002